Adherence-resistance relationships to combination HIV antiretroviral therapy.
about
Getting to 90-90-90 in paediatric HIV: What is needed?Associations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America.Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention.Strategies for promoting adherence to antiretroviral therapy: a review of the literatureCorrelates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS.Adherence to antiretroviral therapy and HIV transmission risks: implications for test-and-treat approaches to HIV prevention.Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity.Antiretroviral therapy adherence among patients living with HIV/AIDS in ThailandCumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veteransDelivery of HIV care during the 2007 post-election crisis in Kenya: a case study analyzing the response of the Academic Model Providing Access to Healthcare (AMPATH) programFour types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time.Association between health literacy and HIV treatment adherence: further evidence from objectively measured medication adherence.Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS.Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.Behavioural strategies to reduce HIV transmission: how to make them work better.Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South AfricaAlcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV.Food insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment and health outcomesFood insecurity and antiretroviral adherence among HIV positive adults who drink alcohol.Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adultsAssumed infectiousness, treatment adherence and sexual behaviours: applying the Swiss Statement on infectiousness to HIV-positive alcohol drinkers.Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial.Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance.Risk of triple-class virological failure in children with HIV: a retrospective cohort studyIndividualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South AfricaPharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected childrenAn update on the use of Atripla in the treatment of HIV in the United States.Synergistic effects of food insecurity and drug use on medication adherence among people living with HIV infection.Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIVDeep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.Association of knowledge on ART line of treatment, scarcity of treatment options and adherenceIntentional Medication Nonadherence Because of Interactive Toxicity Beliefs Among HIV-Positive Active Drug Users.HIV Stigma in Prisons and Jails: Results from a Staff Survey.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children
P2860
Q30385352-2CD33F27-8FE5-40D2-8E97-25DA381C22FDQ31125998-39B47CBE-0990-4EF3-B3C5-149140188AEEQ33640410-259CE2B1-8791-479E-9794-3924F28E31F1Q33725057-C5AFDC5F-5BD7-4199-8ADC-1CCE89432AB8Q33764003-2E8AD781-C66A-4814-ABCA-31BBCAFA7D67Q33774290-FA967A16-40D3-4FA8-8D43-EF0DFF243C47Q33796930-3326EA02-88F5-43B3-998C-953B91F07A9EQ33874948-E878FE1A-82FB-4FE2-86D4-8FF598DA09CCQ33981074-71BFB9F0-316A-43A6-B954-670F1CFCA8F8Q34118239-74CF5DE3-1BAC-432D-AAD0-91AADD10EEFDQ34165125-65650C69-7B8E-4055-9717-CBF2F3DCA1FCQ34173349-E720CF5C-959C-4329-83A5-F59479B0B60AQ34250217-5A6DB141-3705-42FC-B25A-E5573B6D8F41Q34373751-76ECFABF-579D-46C8-AE4A-C9BD4E6C9077Q34462506-F1BA893F-B3B7-4AC4-859D-EE748A979C5EQ34468878-38F91EB6-27FD-4005-931B-4508CEB20B48Q34495138-C179C227-5F06-4CC4-BD3A-D6E9A78A419AQ34595298-34A98260-FBFC-44B2-9BE4-7C43B0E0588BQ34624904-152D8FB8-9BE8-44CF-B685-02D28361301CQ34741832-E1EF4302-BB33-41CE-B115-A1F114619939Q34742623-4A29ED44-4702-4382-A855-D3B8DF5E7052Q34816254-8E452A0E-0D8A-4E87-B406-9799B8E744F4Q34817650-B4EAAEFB-D27C-4BE2-9D82-67CEC1C9FE9CQ34820367-F4D614C7-1895-4A8E-BAF4-661A27C06CAAQ34904234-FD47C96C-FC81-4ADF-ADD6-B89305C95757Q34937254-F4DE0EDC-C5D8-4EC4-8723-FB0BFF31C507Q34997180-86FA297A-E4A5-433C-B407-25C710A33356Q35175477-2F1EC95E-1D72-42B4-9266-92853DCAB6E5Q35217629-79D00CE7-7A8D-45CF-B808-9F6C7CADAD9EQ35364313-A84DF103-4EC0-4A61-8BCB-9E34A26E4052Q35371115-E065F5E3-C829-4FA0-B2A7-3649CBCF29EFQ35557269-66C72FE0-EBFB-4596-9AB9-66560EC0452BQ35587302-0E835457-2A03-4E54-89EE-9763F7BD5649Q35699612-365327D7-F09D-4357-89FD-12112EC8301CQ35842104-37E775C1-2FCA-474B-916D-8EC412EEC80AQ36023047-1A8079F8-D0AE-4935-A2A9-FD827C2EA227Q36077969-A0789AC7-F39C-47B9-8AA5-C6AA68B64E60Q36289131-5F44CAC2-5F3F-44CA-8D39-7699F2D8A584Q36345603-3C71234F-00B3-4E8F-BD9A-2EFAC29B613DQ36349683-06003925-777E-4C46-BCBD-BA242EC33EBC
P2860
Adherence-resistance relationships to combination HIV antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@ast
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@en
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@nl
type
label
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@ast
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@en
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@nl
prefLabel
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@ast
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@en
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@nl
P1476
Adherence-resistance relationships to combination HIV antiretroviral therapy.
@en
P2093
Deanna L Kroetz
P2888
P356
10.1007/S11904-007-0010-0
P577
2007-05-01T00:00:00Z